Amal Therapeutics Company
Amal Therapeutics SA is a privately held Swiss/German biotech start-up company and spin-off from the University of Geneva.
Investors
.png)
Technology:
Peptides and Proteins
Industry:
Peptides and Proteins
Headquarters:
Geneva, Geneve, Switzerland
Founded Date:
2012-01-01
Employees Number:
11-50
Funding Status:
M&A
Investors Number:
9
Total Funding:
45336548
Estimated Revenue:
$1M to $10M
Last Funding Date:
2018-11-12
Last Funding Type:
Series B
Register and Claim Ownership